Ocular Therapeutix Inc
Change company Symbol lookup
Select an option...
OCUL Ocular Therapeutix Inc
GOOG Alphabet Inc
BAC Bank of America Corp
ED Consolidated Edison Inc
FRAN Francesca's Holdings Corp
CWBHF Charlotte's Web Holdings Inc
SALM Salem Media Group Inc
FUN Cedar Fair LP
NWFFX American Funds New World Fund® Class F-1

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase III clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase III clinical development for glaucoma and ocular hypertension. Its earlier stage assets include OTX-TIC, a sustained release travoprost intracameral injection for the treatment of moderate to severe glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. These injections include the development of OTX-TKI, a tyrosine kinase inhibitor, and, in collaboration with Regeneron an extended release protein-based anti-vascular endothelial growth factor trap.

Closing Price
Day's Change
0.39 (4.41%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Allergic Conjunctivitis Market to Exhibit 5.4% CAGR and Reach $3.05 Billion by 2027; Massive Investments in Clinical Trials to Boost Growth

10:47 am ET September 3, 2020 (Globe Newswire) Print

The global allergic conjunctivitis market size is projected to gain significant revenue in the coming years on account of the increasing awareness about availability of these drugs. As per a Fortune Business Insights report titled, "Allergic Conjunctivitis Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, and Others), By Disease Type (Mild, and Severe), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027" the value of this market was USD 2.50 billion in 2019 and is expected to rise at a CAGR of 5.4% to reach USD 3.05 billion by the end of 2027. The forecast period is set between 2020 and 2027.

The report answers the following questions:

-- What is the nature of the market?

-- Who are the key players of this market and what are their major strategies?

-- What is the impact of the COVID-19 pandemic on the market?

-- What are the recent industry developments of the market?

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/allergic-conjunctivitis-market-100121

Drivers & Restraints

Rising Awareness about Availability of Drugs to Augment Growth

The increasing patient pool for allergic conjunctivitis stands as a key factor propelling the global allergic conjunctivitis market growth. The increasing development of new treatment options, and massive investments on clinical trials will also boost the market. This coupled with the rise in air pollution levels in cities, and weather changes may further intensify the level of itchiness and accordingly worsen the condition, thereby boosting the market in the forecast period.

On the contrary, most of the time this illness is ignored by patients and therefore they do not opt for medical assistance. Therefore, the lack of awareness and ignorance of people towards the treatment of this conjunctivitis may hamper the market in the coming years.

Despite this, the presence of strong patient population and the rising awareness about the availability of various therapeutic drugs are likely to create lucrative growth opportunities for the market in the coming years.

The COVID-19 pandemic has brought the world economy in a bad shape. Most of the businesses are temporarily shut with the imposition of stringent social distancing rules by the governments of various nations. However, intense research and development activities on the invention of an antidote to fight the novel coronavirus will soon help us come out of this situation altogether.

The impact of COVID-19 pandemic on various markets have been discussed in detail and provided in the form of analytical reports by Fortune Business Insights. These reports will help investors study the market and its trajectories and accordingly invest in the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/allergic-conjunctivitis-market-100121


Antihistamines & Mast Cell Stabilizers Segment to Gain Dominance Owing to its High Adoption

Among all drug class, the antihistamines & mast cell stabilizers segment earned the highest share on account of its high adoption rate, further attributed to their diagnostic efficiency. In 2019, this segment earned an allergic conjunctivitis market share of 77.4%

Regional Analysis-

North America Dominated Market Owing to Prevalence of Allergic Conjunctivitis

Among all regions, North America emerged dominant owing to the strong prevalence of this conjunctivitis in the region, coupled with the increasing healthcare infrastructure and facilities. In 2019, this region earned USD1.20 billion owing to the presence of major vendors and the availability of supportive reimbursement policies.

Quick Buy - Allergic Conjunctivitis Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100121

Competitive Landscape-

Bausch & Lomb, Allergan, and Alcon Hold Significant Shares Owing to Strong Portfolio

The nature of the global allergic conjunctivitis market is perfectly competitive in nature owing to the presence of small, medium, and large players. Currently, companies such as Alcon, Bausch & Lomb, and Allergan are currently holding the major shares. This is attributable to the strong product portfolio. The other players are focusing on getting product approvals and launching new products to gain a competitive edge in the market competition.

Industry Developments

February 2020 - The first ever and only eye drop to provide all day relief from allergic itches was launched by Alcon in the name of Pataday Once Daily Relief.

July 2020 - A new drug molecule for treating allergic conjunctivitis was introduced by Eyevance Pharmaceuticals LLC in the name of Cetirizine ophthalmic solution.

List of the Leading Companies Profiled in the Allergic Conjunctivitis Market Research Report are:

-- Santen Pharmaceutical Co., Ltd. (Osaka, Japan)

-- Alcon (Geneva, Switzerland)

-- Eyevance Pharmaceuticals LLC (Forth Worth, U.S.)

-- Ocular Therapeutix, Inc. (Bedford, U.S.)

-- Allergan (AbbVie Inc.) (Dublin, Ireland)

-- Bausch & Lomb (Laval, Canada)

-- Novartis AG (Basel, Switzerland)

-- Sun Pharmaceutical Industries Ltd. (Mumbai, India)

-- Eton Pharmaceutical (Deer Park, U.S.)

-- Others

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/allergic-conjunctivitis-market-100121

Table of Contents:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Prevalence of Allergic Conjunctivitis - By Key Countries

        -- Prevalence of Allergic Conjunctivitis - By Key Countries

        -- Pipeline Analysis

        -- Key Industry Developments

        -- New Product Launches

        -- Impact of COVID-19 on the Allergic Conjunctivitis Market

        -- Allergy - Statistics and Facts

        -- Global Allergic Conjunctivitis Market Analysis, Insights and Forecast, 2016-2027

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Drug Class

            -- Antihistamines & Mast Cell Stabilizers

            -- Antihistamines & Mast Cell Stabilizers

            -- Corticosteroids

            -- Others

            -- Market Analysis, Insights and Forecast - By Disease Type

              -- Mild Allergic Conjunctivitis

              -- Mild Allergic Conjunctivitis

              -- Severe Allergic Conjunctivitis

              -- Market Analysis, Insights and Forecast - By Distribution Channel

                -- Hospital Pharmacies

                -- Hospital Pharmacies

                -- Drug Stores & Retail Pharmacies

                -- Online Pharmacies

                -- Market Analysis, Insights and Forecast - By Region

                  -- North America

                  -- North America

                  -- Europe

                  -- Asia Pacific

                  -- Latin America

                  -- Middle East & Africa

                  TOC Continued....!

                  Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/allergic-conjunctivitis-market-100121

                  Have a Look at Related Reports:

                  Ophthalmic Disease Therapeutics Market Share and Global Trend By Disease Indication (Glaucoma, Retinal Diseases, Dry Eye Disease, Allergy & Infections), By Drug Class (Anti-inflammatory, Anti-infectives, Anti-VEGF, Anti-glaucoma), By Dosage Form (Solid, Liquid, Semi-solid), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Geography Forecast till 2026

                  Ophthalmic Devices Market Share & Industry Analysis, By Product Type (Ophthalmic Surgical Devices, Ophthalmic Diagnostic Devices, and Vision Care Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026

                  Ophthalmic Diagnostic Devices Market Share & Industry Analysis, By Product Type (Optical Coherence Tomography, Aberrometer & Topography Systems, Fundus Camera, Ophthalmic Ultrasound, and Other Ophthalmic Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026

                  Ophthalmic Lasers Market Share and Global Trend By Type (Excimer Lasers, Femtosecond Lasers, Nd Yag Lasers, Diode Lasers), Technology (Photodisruption, Selective Laser Trabeculoplasty, Photocoagulation), Application (Cataract Treatment, Glaucoma Treatment, Refractive Errors Treatment), End-User (Ophthalmic Laser Centers,Hospitals ) & Geography Forecast till 2026

                  Ophthalmic Surgical Devices Market Share & Industry Analysis, By Surgery Type (Cataract Surgery Devices, Vitreoretinal Surgery Devices, Refractive Error Surgery Devices, Glaucoma Surgery Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026

                  About Us:

                  Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                  Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                  At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                  Contact Us:

                  Fortune Business Insights(TM) Pvt. Ltd.

                  308, Supreme Headquarters,

                  Survey No. 36, Baner,

                  Pune-Bangalore Highway,

                  Pune - 411045, Maharashtra, India.


                  US :+1 424 253 0390

                  UK : +44 2071 939123

                  APAC : +91 744 740 1245

                  Email: sales@fortunebusinessinsights.com

                  Fortune Business Insights(TM)

                  LinkedIn | Twitter | Blogs

                  Press Release: https://www.fortunebusinessinsights.com/press-release/global-allergic-conjunctivitis-market-10195


                  comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.